- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 253/04 - Triazines-1, 2, 3
Détention brevets de la classe C07D 253/04
Brevets de cette classe: 19
Historique des publications depuis 10 ans
1
|
0
|
2
|
0
|
1
|
0
|
2
|
1
|
4
|
0
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Takeda Pharmaceutical Company Limited | 2961 |
2 |
University of Virginia Patent Foundation | 1470 |
2 |
Canon Inc. | 36841 |
1 |
Daikin Industries, Ltd. | 9495 |
1 |
Dongjin Semichem Co., Ltd. | 438 |
1 |
Fibrotech Therapeutics PTY LTD | 7 |
1 |
FUJIFILM Electronic Materials U.S.A., Inc. | 270 |
1 |
Leo Laboratories Limited | 61 |
1 |
Nissan Chemical Industries, Ltd. | 1822 |
1 |
The Provost, Fellows, Foundation Scholars, & The Other Members of Board, of The College of The Holy and Undiv. Trinity of Queen Elizabeth, Near Dublin | 6 |
1 |
Ranbaxy Laboratories Limited | 453 |
1 |
The Regents of the University of Colorado, a body corporate | 2430 |
1 |
The Scripps Research Institute | 1364 |
1 |
The University of Melbourne | 499 |
1 |
Certa Therapeutics Pty. Ltd. | 11 |
1 |
Toray Advanced Materials Research Laboratories (China) Co., Ltd. | 34 |
1 |
z Factor Limited | 19 |
1 |
Autres propriétaires | 0 |